Mostrar el registro sencillo del ítem

dc.contributor.author
Laconi, Myriam Raquel  
dc.contributor.author
Casteller, Guillermo  
dc.contributor.author
Gargiulo, Pascual Angel  
dc.contributor.author
Bregonzio Diaz, Claudia  
dc.contributor.author
Cabrera Kreiker, Ricardo Jorge  
dc.date.available
2022-10-05T14:18:58Z  
dc.date.issued
2001-04  
dc.identifier.citation
Laconi, Myriam Raquel; Casteller, Guillermo; Gargiulo, Pascual Angel; Bregonzio Diaz, Claudia; Cabrera Kreiker, Ricardo Jorge; The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats; Elsevier Science; European Journal of Pharmacology; 417; 1-2; 4-2001; 111-116  
dc.identifier.issn
0014-2999  
dc.identifier.uri
http://hdl.handle.net/11336/171955  
dc.description.abstract
The behavioural display in the plus-maze, an established experimental model of anxiety, was studied in rats injected into the lateral brain ventricle (i.c.v.) with the neurosteroid 3α-hydroxy-5α-pregnan-20-one (allopregnanolone). Female rats under different gonadal hormonal status were chosen. Allopregnanolone enhanced exploration of the open arms in both estrous rats and ovariectomized estrogen and progesterone primed rats. No effect was observed in diestrous 1 and ovariectomized not-primed rats. In all cases, the plus-maze locomotor-exploratory behaviour was not affected by allopregnanolone. The GABAA receptor antagonist, bicuculline (9.8 μM i.c.v.) reversed the allopregnanolone action in the ovariectomized primed rats. When bicuculline was injected i.c.v. in conjunction with allopregnanolone, the anxiogenic effect of bicuculline was reversed by the highest dose (25 μM) of allopregnanolone only. These results suggest that allopregnanolone exerts an anxiolytic action interacting with the GABAA receptor in an estrogen-dependent manner. © 2001 Elsevier Science B.V.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ALLOPREGNANOLONE  
dc.subject
ANXIETY  
dc.subject
ESTROUS CYCLE  
dc.subject
GABAA RECEPTOR  
dc.subject
NEUROSTEROID  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2021-12-03T20:25:53Z  
dc.journal.volume
417  
dc.journal.number
1-2  
dc.journal.pagination
111-116  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Laconi, Myriam Raquel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina  
dc.description.fil
Fil: Casteller, Guillermo. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina  
dc.description.fil
Fil: Gargiulo, Pascual Angel. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina  
dc.description.fil
Fil: Bregonzio Diaz, Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina  
dc.description.fil
Fil: Cabrera Kreiker, Ricardo Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Cuyo. Facultad de Ciencias Medicas. Departamento de Neurociencias; Argentina  
dc.journal.title
European Journal of Pharmacology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0014299901008652  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/S0014-2999(01)00865-2